Labeling hydroxymethylated residues
DCFirst Claim
Patent Images
1. A method comprising:
- (a) labeling covalently, a hydroxyl group on a hydroxymethylated residue in a mammalian nucleic acid to generate a labeled 5-hydroxymethylcytosine residue, wherein said labeling comprises glycosylating the hydroxyl group by employing an alpha-glucosyltransferase, a beta-glucosyltransferase, or a beta-glucosyl-alpha-glucosyl-transferase; and
(b) sequencing said mammalian nucleic acid comprising said labeled hydroxymethylated residue.
5 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The present invention provides for novel methods for regulating and detecting the cytosine methylation status of DNA. The invention is based upon identification of a novel and surprising catalytic activity for the family of TET proteins, namely TET1, TET2, TET3, and CXXC4. The novel activity is related to the enzymes being capable of converting the cytosine nucleotide 5-methylcytosine into 5-hydroxymethylcytosine by hydroxylation.
-
Citations
7 Claims
-
1. A method comprising:
-
(a) labeling covalently, a hydroxyl group on a hydroxymethylated residue in a mammalian nucleic acid to generate a labeled 5-hydroxymethylcytosine residue, wherein said labeling comprises glycosylating the hydroxyl group by employing an alpha-glucosyltransferase, a beta-glucosyltransferase, or a beta-glucosyl-alpha-glucosyl-transferase; and (b) sequencing said mammalian nucleic acid comprising said labeled hydroxymethylated residue. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
Specification